Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pink Elephant is an active private healthcare-focused venture builder and investor centered on psychedelics, medical cannabis, and progressive mental health care. The company describes itself as building and funding fast-growing ventures that expand safe access to these therapies, with a particular focus on evidence-based, legally compliant models. Its areas of interest span telemedicine, diagnostics, clinics, retreat centers, media, ed-tech, AI agents, wearables, and e-commerce rather than a traditional single-asset drug pipeline. Based on its public materials, Pink Elephant appears to operate more as a venture studio and ecosystem builder in mental health than as a conventional biotech or pharmaceutical developer. The company emphasizes jurisdictions with evolving legal frameworks and seeks to support founders, clinicians, and operators developing next-generation mental health businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pink Elephant.